The Impact of an Inquisitive and Ethical Mind: Remembering Frances Oldham Kelsey

Kelsey, MD (’50), PhD (’38) spurred landmark reformations in the way the FDA evaluates a drugs’ safety and efficacy, passed away on August 7th 2015, at 101 years of age. Click here for the full article.

Frances Oldham Kelsey, MD (’50), PhD (’38), whose refusal to approve the drug thalidomide without extensive safety testing spurred landmark reformations in the way the FDA evaluates a drugs’ safety and efficacy, passed away on Friday, August 7th, at 101 years of age.

Click here to read the full article.